Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Langerhans cell histiocytosis.

T Chu1

  • 1Section of Dermatology, Imperial College of Science, Technology and Medicine, Hammersmith Campus, DuCane Road, London W12 0NN, United Kingdom. a.chu@ic.ac.uk

The Australasian Journal of Dermatology
|March 21, 2002
PubMed
Summary

Langerhans cell histiocytosis (LCH) is a rare clonal disorder affecting any organ. Early diagnosis is crucial for prognosis, especially in adults, with dermatologists often managing complex cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Construction of competitive endogenous RNA regulatory network and clinical verification for repeated implantation failure].

Zhonghua yi xue za zhi·2024
Same author

Bioenergetic stress potentiates antimicrobial resistance and persistence.

bioRxiv : the preprint server for biology·2024
Same author

[The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory].

Molekuliarnaia biologiia·2024
Same author

The Relationship between Psychological Distress and Physical Frailty in Japanese Community-Dwelling Older Adults: A Cross-Sectional Study.

The Journal of frailty & aging·2023
Same author

[The influence of various myelosuppression degrees during neoadjuvant chemotherapy on the curative effect and prognosis of triple-negative breast cancer].

Zhonghua yi xue za zhi·2022
Same author

Equations of motion for weakly compressible point vortices.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2022

Area of Science:

  • Dermatology
  • Oncology
  • Immunology

Background:

  • Langerhans cell histiocytosis (LCH) is a rare multisystemic disorder.
  • It is characterized by the clonal proliferation of activated Langerhans cells.
  • Tissue damage in LCH is linked to local cytokine release.

Purpose of the Study:

  • To highlight the importance of rapid diagnosis in Langerhans cell histiocytosis.
  • To discuss current understanding of LCH pathogenesis and treatment.
  • To emphasize the role of dermatologists in managing LCH.

Main Methods:

  • Review of current literature on Langerhans cell histiocytosis.
  • Classification of LCH as a class I histiocytosis.
  • Analysis of treatment strategies based on disease severity.

Main Results:

  • LCH diagnosis time impacts prognosis, particularly in adults.
  • Etoposide is effective for resistant or multisystem LCH.
  • Maintenance therapy may involve azathioprine, 6-mercaptopurine, or methotrexate.

Conclusions:

  • Langerhans cell histiocytosis requires prompt diagnosis for better outcomes.
  • Treatment varies from local therapy to chemotherapy and maintenance regimens.
  • Dermatologists experienced in chronic diseases are well-suited to manage LCH patients.

Related Experiment Videos